9 results
8-K
EX-99.4
ELTX
Elicio Therapeutics Inc.
2 Jun 23
Angion Biomedia Corp. Announces 1-for-10 Reverse Stock Split
4:36pm
. Such side effects could also affect patient recruitment or the ability of enrolled patients to complete the trial or result in potential product liability
424B3
ELTX
Elicio Therapeutics Inc.
28 Apr 23
Prospectus supplement
4:07pm
affect patient recruitment or the ability of enrolled patients to complete the trial or result in potential product liability claims. Any … $160,000 for potential patient recruitment bonuses from a terminated clinical study that will not be realized (subject to Elicio’s due diligence
S-4/A
gj5gx
29 Mar 23
Registration of securities issued in business combination transactions (amended)
5:29pm
S-4/A
EX-10.26
003t6w9md0ul93n5pe4y
29 Mar 23
Registration of securities issued in business combination transactions (amended)
5:29pm
- Prev
- 1
- Next